Unknown

Dataset Information

Assessment of measurement properties of peak VO(2) in children with pulmonary arterial hypertension.


ABSTRACT:

Background

The 6-minute walk test evaluates the effect of pharmacologic intervention in adults with pulmonary arterial hypertension (PAH) but, for reasons of compliance or reliability, may not be appropriate for children at all ages. Thus, peak oxygen consumption (VO2, maximal exercise test) was used instead in a pediatric PAH trial (STARTS-1) to evaluate pharmacologic intervention with sildenafil. This was the first large placebo-controlled trial to use the peak VO2 endpoint in this population. Our working hypothesis was that, as with other populations, percentage changes in peak VO2 in pediatric patients with PAH are reliable and are associated with changes in other clinical endpoints.

Methods

Using data from the subpopulation of 106 patients who were developmentally and p

SUBMITTER: Cappelleri JC 

PROVIDER: S-EPMC3528474 | biostudies-literature | 2012 Sep

REPOSITORIES: biostudies-literature